Status:

COMPLETED

Efficacy of a Cosmetic Shampoo RV3438G in Reccurent Squamous States

Lead Sponsor:

Pierre Fabre Dermo Cosmetique

Conditions:

Dermatitis, Seborrheic

Eligibility:

All Genders

18-60 years

Brief Summary

The aim of the study is to evaluate, with clinical, biological and biometrological assessment methods, the effectiveness of RV3438G shampoo, after 2 weeks of short intensive treatment phase and also t...

Detailed Description

4 visits are performed: Visit 1: Inclusion (Day1) : start of the short intensive treatment phase (phase 1) Visit 2: Intermediate visit (Day15 ± 3 days, Week 2) : end of the short treatment intensive p...

Eligibility Criteria

Inclusion

  • Criteria related to the population:
  • \- Subject aged between 18 and 60 years included
  • Criteria related to the disease:
  • Subject having a squamous state of the scalp :
  • clinically visible (Squire score ≥ 20),
  • with an intensity of the squamous state superior or equal to 2 on a scale from 0 to 3 on at - least 1 of the 4 scalp areas
  • recurrent (at least twice a year)
  • associated to erythema and pruritus: erythema scoring superior or equal to 1 on a scale from 0 to 3 on at least 1 scalp area desquamating of the 4 scalp areas pruritus scoring assessed by the subject superior or equal to 3 on a numerical scale from 0 to 10 (mean pruritus felt on the last 3 days)

Exclusion

  • Criteria related to the diseases / skin condition:
  • Subject having frizzy hair
  • Subject with an alopecia having caused hair loss on the upper part of the scalp (Norwood Hamilton stage\> III, Ludwig ≥ I-4, alopecia aerata, alopecia totalis), Seborrheic dermatitis requiring medical treatment
  • Criteria related to treatments and/or products:
  • Systemic treatment with nonsteroidal anti-inflammatory, corticosteroid, antibiotic, antihistamine taken during 5 consecutive days within the 2 weeks before the inclusion or planned during the study and liable to interfere with the study assessments
  • Topical treatment or product applied on the scalp within 2 weeks before the inclusion or planned during the study that can be active on squamous states or that can limit the effectiveness of the study product: anti-inflammatory drugs, ketoconazole, anti-dandruff shampoo, anti-fungal, rinse with vinegar, essential oils ...
  • Any scalp dyeing, bleaching, perm, smoothing / straightening performed within 2 weeks before inclusion

Key Trial Info

Start Date :

November 9 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 11 2021

Estimated Enrollment :

63 Patients enrolled

Trial Details

Trial ID

NCT06578962

Start Date

November 9 2020

End Date

May 11 2021

Last Update

August 30 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Centre de Santé Sabouraud - Hôpital Saint Louis

Paris, France, 75010